Veru, Inc. (VERU)
2.30
-0.14
(-5.74%)
USD |
NASDAQ |
Oct 16, 16:00
2.29
-0.01
(-0.43%)
After-Hours: 20:00
Veru Cash from Operations (Quarterly) : -5.467M for June 30, 2026
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -5.467M |
| March 31, 2026 | -8.915M |
| December 31, 2025 | -6.170M |
| September 30, 2025 | -5.491M |
| June 30, 2025 | -5.482M |
| March 31, 2025 | -7.736M |
| December 31, 2024 | -11.33M |
| September 30, 2024 | -4.366M |
| June 30, 2024 | -5.646M |
| March 31, 2024 | -5.65M |
| December 31, 2023 | -6.020M |
| September 30, 2023 | -9.492M |
| June 30, 2023 | -18.43M |
| March 31, 2023 | -25.56M |
| December 31, 2022 | -34.53M |
| September 30, 2022 | -20.88M |
| June 30, 2022 | -14.02M |
| March 31, 2022 | -3.947M |
| December 31, 2021 | -8.658M |
| September 30, 2021 | -0.8065M |
| June 30, 2021 | -12.83M |
| March 31, 2021 | -2.590M |
| December 31, 2020 | 0.6592M |
| September 30, 2020 | -0.3411M |
| June 30, 2020 | 3.338M |
| Date | Value |
|---|---|
| March 31, 2020 | -2.417M |
| December 31, 2019 | -2.510M |
| September 30, 2019 | -0.955M |
| June 30, 2019 | -0.5276M |
| March 31, 2019 | -2.496M |
| December 31, 2018 | -1.506M |
| September 30, 2018 | -2.815M |
| June 30, 2018 | -4.428M |
| March 31, 2018 | -4.600M |
| December 31, 2017 | 0.2967M |
| September 30, 2017 | 0.5774M |
| June 30, 2017 | 1.466M |
| March 31, 2017 | -2.226M |
| December 31, 2016 | 1.166M |
| September 30, 2016 | -0.8227M |
| June 30, 2016 | 0.42M |
| March 31, 2016 | -0.8804M |
| December 31, 2015 | -0.4312M |
| September 30, 2015 | 1.489M |
| June 30, 2015 | -0.2084M |
| March 31, 2015 | -1.609M |
| December 31, 2014 | -1.220M |
| September 30, 2014 | 2.184M |
| June 30, 2014 | 0.3152M |
| March 31, 2014 | -0.0158M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 56.67M |
| Corcept Therapeutics, Inc. | 33.54M |
| Johnson & Johnson | -- |
| Eli Lilly & Co. | 10.69B |
| Lexicon Pharmaceuticals, Inc. | -9.192M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 1.802M |
| Cash from Financing (Quarterly) | -0.0519M |
| Free Cash Flow | -26.04M |
| Free Cash Flow Per Share (Quarterly) | -0.2372 |
| Free Cash Flow to Equity (Quarterly) | -5.317M |
| Free Cash Flow to Firm (Quarterly) | -5.467M |
| Free Cash Flow Yield | -55.87% |